ENTITY Angelini Pharma

Angelini Pharma

PulseAugur coverage of Angelini Pharma — every cluster mentioning Angelini Pharma across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

0

0 over 90d

TIER MIX · 90D

TOPICS

TIMELINE

2026-08-20 funding Angelini Pharma acquired Catalyst Pharmaceuticals for $4.1 billion, marking a significant expansion into the US rare disease market. source

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

RESEARCH · CL_210844 · Aug 20 · 10:30

Italy's Angelini Pharma buys US biotech Catalyst for $4.1B

The Angelini family, an Italian pharmaceutical dynasty with an estimated net worth of $10 billion, has significantly expanded its global reach by acquiring the U.S.-based rare disease biotech Catalyst Pharmaceuticals fo…